NEW

Activ Surgical Announces FDA Clearance for ActivSight Intraoperative Imaging Module

Activ Surgical announced the U.S. Food and Drug Administration (FDA) 510(k) clearance of the company’s ActivSight Intraoperative Imaging Module for enhanced surgical visualization.

Metrex Surface Disinfectant Portfolio Secures EPA Approval

The U.S. Environmental Protection Agency (EPA) has approved all eight surface disinfectant products made by an infection prevention leader, Metrex, as effective against SARS-CoV-2, the novel coronavirus that causes COVID-19.

Olympus Supports Safety Actions Regarding Surgical Smoke

Olympus has announced its support of The Joint Commission’s recommended safety actions for managing the hazards of exposure to surgical smoke for health care staff in operating rooms.

Exofin Fusion Redesign Receives FDA Approval

Chemence Medical, a leader in medical cyanoacrylate devices and products, announced the U.S. Federal Drug Administration’s (FDA) 510(k) approval of the company’s redesigned exofin fusion skin closure system.

3M: C. diff Solution Tablets

3M C. diff Solution Tablets provide a proven, effective alternative to bleach and peracetic acid disinfectants, featuring an NFPA rating of 0,0,0 with no personal protective equipment required at use dilution. EPA-registered to kill C. diff spores in four minutes and effective against Norovirus, the product dissolves in approximately three minutes and can be applied with a cloth, wipe, mop or coarse trigger sprayer. Additionally, 3M C. diff Solution Tablets cost significantly less than ready-to-use bleach, yielding a three-year shelf life in sealed packets, and a seven-day shelf life when diluted and stored in a closed container.

Next Product: Bleach Germicidal Wipes

Previous

Next

Trackbacks/Pingbacks

  1. Ruhof: Biocide Detergent Disinfectant Pump Spray | OR Today - […] Next Product: C. diff Solution Tablets […]

Submit a Comment

Your email address will not be published. Required fields are marked *

X